|
AHN QSV CPHQ Study Group 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHN Quality Webinar Series 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHN Quality Webinar Series 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHN Surgical Oncology M & M 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHN Surgical Oncology M & M 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHN Surgical Oncology Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHN Surgical Oncology Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHN Wexford STARRT 2023 |
|
10/18/2023 to 12/31/2023 |
|
AHN Wexford STARRT 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Hematologic and Cellular Therapy Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Hematologic and Cellular Therapy Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Breast Cancer Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Breast Cancer Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Colon and Rectal Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Colon and Rectal Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Esophageal and Gastric Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Esophageal and Gastric Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Gynecologic Oncology Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Gynecologic Oncology Tumor Board 2024 |
|
01/01/2023 to 12/31/2024 |
|
AHNCI COE Head and Neck Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Head and Neck Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Liver Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Liver Tumor Board 2024 |
|
01/01/2024 to 12/31/2024 |
|
AHNCI COE Lung and Pleural Tumor Board 2023 |
|
01/01/2023 to 12/31/2023 |
|
AHNCI COE Lung and Pleural Tumor Board 2024 |
|
01/01/2023 to 12/31/2023 |
Facebook
Twitter
LinkedIn
Forward